Long-term Immunosuppression
Long-Term Immunosuppression is a maintenance immunosuppressive regimen constituting a sustained, post-transplant pharmacological intervention designed to prevent allograft rejection through continuous modulation of the recipient's immune response beyond the immediate postoperative period.
595
Publications
33.7K
Citations
3.6K
Authors
895
Institutions
Publications per year
2017–2026
96
595
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti, Lionel Rostaing, J.M. Boria Grinyo et al. · New England Journal of Medicine · 2016 · 759 citations · Full text
Frédéric Houssiau, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2010 · 496 citations · Full text
1–5 of 595
3.6K
10
h-index
9
h-index
8
h-index
8
h-index
7
h-index
1–5 of 3.6K
895
Massachusetts General Hospital
Boston, United States
18 h-index
84 publications
7.2K citations
Harvard University
Cambridge, United States
16 h-index
90 publications
8.8K citations
University of California, San Francisco
San Francisco, United States
15 h-index
36 publications
4.9K citations
Inserm
Paris, France
14 h-index
71 publications
9.2K citations

University of Minnesota
Minneapolis, United States
14 h-index
92 publications
5.5K citations
University of Pittsburgh
Pittsburgh, United States
13 h-index
73 publications
9.5K citations

Johns Hopkins Medicine
Baltimore, United States
12 h-index
67 publications
1.7K citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
12 h-index
28 publications
1.3K citations
1–8 of 895
110 publications · 5.9K citations
46
h-index
Repository · 77 publications · 3.6K citations
29
h-index
30 publications · 2.2K citations
22
h-index
22 publications · 595 citations
14
h-index
NDT · 10 publications · 620 citations
10
h-index
1–5